gallium-ga-68-dotatate and Carcinoma--Hepatocellular

gallium-ga-68-dotatate has been researched along with Carcinoma--Hepatocellular* in 2 studies

Other Studies

2 other study(ies) available for gallium-ga-68-dotatate and Carcinoma--Hepatocellular

ArticleYear
Re: Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CT.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:3

    Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography

2020
Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CT.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:4

    Ga-DOTATATE is a radiolabeled somatostatin analog used for the detection and characterization of somatostatin receptor (SSR)-overexpressing tumors, particularly well-differentiated neuroendocrine tumors. We present a case of a 65-year-old man with well-differentiated pancreatic neuroendocrine tumor post-Whipple surgery and a new liver lesion on CT. Ga-DOTATATE PET/CT was performed for SSR characterization and restaging, which demonstrated the lesion to be intensely SSR positive and interpreted as a neuroendocrine metastasis. However, subsequent pathology proved the lesion to be a hepatocellular carcinoma. This case adds hepatocellular carcinoma as a potentially DOTATATE-avid malignancy to be considered in the differential diagnoses of SSR-positive liver lesions.

    Topics: Aged; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin

2019